We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Safety and Efficacy of MERS Treatment Confirmed in Phase I Trial

News   Jan 11, 2018 | Original story from National Institutes of Health

 
Safety and Efficacy of MERS Treatment Confirmed in Phase I Trial

The round, spiked objects at center are MERS coronavirus particles. Credit: NIAID

 
 
 

RELATED ARTICLES

Glioblastoma Overcomes Treatment Resistance in Promising Preclinical Study

News

A novel method of overcoming treatment resistance to both PD-1 and adoptive cellular therapy has been identified, by employing a concomitant hematopoietic stem and progenitor cell transfer.

READ MORE

New Approach for Controlling Dengue Fever and Zika virus

News

Gene-editing tool to disrupt serotonin receptor linked to egg production in Aedes aegypti mosquitoes.

READ MORE

E-cigarette Flavorings Change Chemistry & Create Irritants

News

The sweet flavors’ appeal to teens is a major concern for Food and Drug Administration officials, who recently declared teen vaping an epidemic. New research shows flavorings are transforming more than marketing. The chemical additives react to e-liquid, or e-juice, creating new compounds that could trigger irritation and inflammation when inhaled.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE